Intelligence Platform

Patents

Browse 2,465 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 7476382

Reovirus for the treatment of neoplasia

ONCOLYTICS BIOTECH INC. · Granted Tue Jan 13 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7470660

Treatment for dark adaptation

The Regents of the University of California · Granted Tue Dec 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7470431

Use of neurotoxin therapy for treatment of urological-neurological disorders associated wi

The Regents of the University of Colorado · Granted Tue Dec 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7468419

Cyclosporin derivatives for the treatment of immune disorders

Enanta Pharmaceuticals, Inc. · Granted Tue Dec 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7465715

Method for treatment of multiple sclerosis

CAN-FITE BIOPHARMA LTD. · Granted Tue Dec 16 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7455845

Use of neurotoxin therapy for treatment of urologic and related disorders related to lower

The Regents of the University of Colorado · Granted Tue Nov 25 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7452723

Methods for preventing reovirus recognition for the treatment of cellular proliferative di

ONCOLYTICS BIOTECH INC. · Granted Tue Nov 18 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7449570

Use of nucleoside compounds for nonsense suppression and the treatment of genetic diseases

PTC THERAPEUTICS, INC. · Granted Tue Nov 11 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 06 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7449192

Use of neurotoxin therapy for treatment of urologic and related disorders related to neuro

The Regents of the University of Colorado · Granted Tue Nov 11 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 06 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7438931

Methods and compositions for the treatment of angiogenic diseases

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Oct 21 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 16 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7429387

Use of botulinum toxin therapy for treatment of recalcitrant voiding dysfunction

The Regents of the University of Colorado · Granted Tue Sep 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7423015

Antihelminthic drugs as a treatment for hyperproliferative diseases

The Board of Regents of the University of Texas System · Granted Tue Sep 09 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7422738

Combined cancer treatment methods using antibodies to aminophospholipids

granted patent

US 7420030

Aminopeptidase A (APA) targeting peptides for the treatment of cancer

The Board of Regents of the University of Texas System · Granted Tue Sep 02 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7417037

Compositions and methods of treatment for inflammatory diseases

The Board of Regents of the University of Oklahoma · Granted Tue Aug 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7416724

Diagnosis and treatment of diseases arising from defects in the tuberous sclerosis pathway

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Aug 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7416741

Copper lowering treatment of inflammatory and fibrotic diseases

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Aug 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7413870

SAK: modulation of cellular proliferation for treatment of cancer

Rigel Pharmaceuticals, Inc. · Granted Tue Aug 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7413873

Method of detection and treatment of colon cancer

The Regents of the University of California · Granted Tue Aug 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7410981

Prodrugs of imidazole derivatives, for use as proton pump inhibitors in the treatment of e

Takeda Pharmaceutical Company Limited · Granted Tue Aug 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7405233

Ureido substituted benzoic acid compounds and their use for nonsense suppression and the t

PTC THERAPEUTICS, INC. · Granted Tue Jul 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7405314

Compounds and methods for the treatment of cancer

The Board of Regents of the University of Texas System · Granted Tue Jul 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7402567

Treatment of disease by inducing cell apoptosis

The United States of America as represented by the Department of Veterans Affairs, Office of the General Counsel (024) · Granted Tue Jul 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7402299

Intracorporeal medicaments for photodynamic treatment of disease

Provectus Pharmatech, Inc. · Granted Tue Jul 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted